Value Set Information
Value Set Code PHVS_VISVaccines_IIS Download Value Set Download Value SetDownload Value SetDownload Value Set
Value Set Name VIS Vaccines (IIS)
Value Set OID 2.16.840.1.114222.4.11.6040
Value Set Description This table lists the vaccines which require that a Vaccine Information Statement (VIS) be shared with a patient/parent. The VIS document type, edition date and presentation date are reported in a set of OBX. Subscribe
Version History

        Concept Code Concept Name Preferred Concept Name Code System Value Set  
215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free Vaccines administered (CVX) VIS Vaccines (IIS) Details
216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free Vaccines administered (CVX) VIS Vaccines (IIS) Details
143 Adenovirus types 4 and 7 Adenovirus, type 4 and type 7, live, oral Vaccines administered (CVX) VIS Vaccines (IIS) Details
24 anthrax anthrax vaccine Vaccines administered (CVX) VIS Vaccines (IIS) Details
174 cholera, live attenuated cholera, live attenuated Vaccines administered (CVX) VIS Vaccines (IIS) Details
212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL Vaccines administered (CVX) VIS Vaccines (IIS) Details
210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL Vaccines administered (CVX) VIS Vaccines (IIS) Details
225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose Vaccines administered (CVX) VIS Vaccines (IIS) Details
230 COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose Vaccines administered (CVX) VIS Vaccines (IIS) Details
301 COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
300 COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose COVID-19 Moderna EUA Recipient-Caregiver Fact Sheet - all ages 6 months and older Vaccines administered (CVX) VIS Vaccines (IIS) Details
218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation Vaccines administered (CVX) VIS Vaccines (IIS) Details
207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose Vaccines administered (CVX) VIS Vaccines (IIS) Details